Socioeconomic characteristics of increased COVID-19 mortality ID’d
Aug 02, 2021
The researchers found that adults living in correctional facilities or in healthcare-related group quarters, those without health insurance coverage, those with family incomes below the federal poverty...
~40 Percent of incident heart failure diagnoses occur in acute care
Jul 27, 2021
Forty-six percent of those with diagnoses in acute care had potential heart failure symptoms in the previous six months.
U.S. surgeon general backs local mask mandates when needed
Jul 19, 2021
Such local orders are consistent with federal guidelines that permit local authorities to require prevention measures.
Hearing impairment tied to poorer physical function
Jul 02, 2021
Hearing impairment is associated with significantly poorer physical function and faster declines in physical function among older people over time compared with those with normal hearing, according to...
Nonsurgical knee arthritis care varies geographically
Jun 16, 2021
Greater use of nonsurgical care was associated with lower rates of total knee arthroplasty.
3 percent of U.S. cancer cases attributable to physical inactivity
Oct 22, 2021
The population-attributable fraction varied from 3.9% for urinary bladder cancer to 16.9% for stomach cancer.
Predictors of smell recovery ID’d in COVID-19 patients
Oct 14, 2021
Age less than 40 years and nasal congestion at the time of COVID-19 infection are positively associated with recovery of smell.
Corticosteroid injections in hip tied to rapidly destructive hip disease
Oct 01, 2021
“While the risk of RDHD following a single low-dose (≤40 mg) triamcinolone injection is low, the risk is higher following high-dose (≥80 mg) injection and multiple injections,” the authors...
Drinking at least two cups of tea daily linked to reduced mortality risk
Aug 30, 2022
An inverse association was seen for mortality from all cardiovascular disease, ischemic heart disease and stroke.
Multidose BCG protects against COVID-19 in at-risk individuals
Aug 16, 2022
An efficacy of 92% was found among at-risk COVID-19-unvaccinated individuals with type 1 diabetes.